Dr. Polite’s Keynote Address at European Cancer Summit Focuses on Quality and Costs of Care

September 19, 2019
Blase Polite, MD, MPA, FASCO, speaks during the 2017 ASCO Oncology Practice Conference

Blase Polite, MD, MPA, FASCO, speaks during the 2017 ASCO Oncology Practice Conference. (ASCO photo by Scott Morgan)

Regardless of whether a patient with cancer lives in the U.S., Europe, or anywhere else in the world, he or she should have the right to the same high-quality care. That was the message of ASCO Board Member Blase N. Polite, MD, MPA, FASCO, in a keynote address to the European Cancer Summit on September 14 that was written up in The Parliament Magazine.

Dr. Polite spoke about the high costs of healthcare in the U.S.—to the point of being a crisis—and the importance of value-based care. Though the U.S. has the bulk of the healthcare cost problems, he does believe that Europe could learn from the U.S. in the area of “value-based payment systems.”

He spoke about the Quality Oncology Practice Initiative (QOPI®) and its 172 measures, all aimed at measuring and assessing various aspects of clinical care. These measures, he stated, help oncologists be accountable for their care.

Dr. Polite’s address was on the final day of the annual summit, which had a theme this year of “European Cancer Care: Across the Borders.”

Read the full article.